News About: Pharm. Industry
Pharmaceutical firms gearing up to fight against government's drug policy
The domestic pharmaceutical industry will call for the government's rational supplementary measures related to the current drug pricing policies, such as a minimum drug pricing system, in parallel with the recent inju...
Highly contagious eye infection spreads to Seoul, other major cities
The recent outbreak of acute hemorrhagic conjunctivitis, called in Korea the "Apollo eye disease," prompted a number of patients to visit eye hospitals and pharmacies are requesting the rapid delivery of eye preparati...
Foreign drug corporations to integrate sales and marketing divisions.
Most of foreign multinational drug corporations are going to reshuffle the organization as for the sales and marketing divisions to consolidate under the one umbrella, and this trend seems to give a strong impact also...
Zyprexa's restricted reimbursement is in dispute
The Ministry of Health and Welfare announced its restricted reimbursement plan on Zyprexa (olanzapine) to take effect on September 1, to this effect that that if other inexpensive drugs compared to Zyprexa are ineffec...
Iressa anti-cancer drug registered in Japan.
A new anti-cancer drug, Iressa originally developed by Astra Zeneca, has been registered in Japan as of Aug. 30 and its NHI price set at 7,216.10 yen per 250mg tablet.
It takes usually 1-2 years for any new drug t...
Increase rates of drug price lag far behind consumer price index
The increase rates of drug prices have been extremely lower than that of the consumer price index (CPI) albeit medical services sector in the surging demands, a pharmaceutical organization said recently.
Acco...
Ads of leading pharmaceutical firms focuses on renowned OTC products in first half
The domestic leading drug makers have concentrated their heavy ads outlays to their renowned OTC brands in the first half of this year, amid more aggressive public campaigns since implementation of the ongoing...
Novo Nordisk to reshuffle company structures.
Novo Nordisk Korea (President: Jeffry James Whitehead) has reshuffle the company structures in order to strengthen their diabetic product market.
The marketing and sales divisions put under the one umbrella and di...
Choong-wae Pharm opens English training course for employees
Choong-wae Pharm is now implementing its own English training program for employees at Songpa Education Institute by recruiting Beverley Burnham-king, an U.S. native speaker, as a full-time employee
The English tr...
Daewoong Pharm spinning off businesses
Daewoong Pharm officially decided on August 30 its plan to separate its business into two parts during a recent special shareholders meeting.
Under the split-off plan, Daewoong Pharm is to break off companies into...
